Skip to main content

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

45.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist

Insider Filings

Form 5
Source: SEC/Edgar
February 12, 2017
Form 3
Source: SEC/Edgar
July 31, 2016
Form 3
Source: SEC/Edgar
December 09, 2015
Form 4
Source: SEC/Edgar
December 06, 2015
Form 3
Source: SEC/Edgar
December 02, 2015
Form 3
Source: SEC/Edgar
December 18, 2014
Form 3
Source: SEC/Edgar
June 18, 2014
Form 3
Source: SEC/Edgar
June 18, 2014
Form 4
Source: SEC/Edgar
March 04, 2013
Form 4/A
Source: SEC/Edgar
October 02, 2012
Form 4
Source: SEC/Edgar
April 01, 2012
Form 4
Source: SEC/Edgar
April 01, 2012
Form 4
Source: SEC/Edgar
April 01, 2012
Form 3
Source: SEC/Edgar
February 13, 2012
Form 3
Source: SEC/Edgar
January 08, 2012
Form 4
Source: SEC/Edgar
December 27, 2011
Form 4/A
Source: SEC/Edgar
December 27, 2011
Form 3
Source: SEC/Edgar
June 08, 2011
Form 4
Source: SEC/Edgar
February 06, 2011
Form 3
Source: SEC/Edgar
January 17, 2011
Form 3
Source: SEC/Edgar
January 12, 2011
Form 3
Source: SEC/Edgar
December 12, 2010
Form 3
Source: SEC/Edgar
December 12, 2010
Form 3
Source: SEC/Edgar
December 12, 2010
Form 3
Source: SEC/Edgar
December 12, 2010
Form 3
Source: SEC/Edgar
March 09, 2009
Form 3
Source: SEC/Edgar
February 26, 2009
Form 3
Source: SEC/Edgar
February 26, 2009
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.